Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2011 1
2013 5
2014 2
2015 11
2016 12
2017 9
2018 7
2019 12
2020 9
2021 18
2022 23
2023 17
2024 16
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Current and future therapies for primary Sjögren syndrome.
Seror R, Nocturne G, Mariette X. Seror R, et al. Among authors: nocturne g. Nat Rev Rheumatol. 2021 Aug;17(8):475-486. doi: 10.1038/s41584-021-00634-x. Epub 2021 Jun 29. Nat Rev Rheumatol. 2021. PMID: 34188206 Review.
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
Spiera RF, Unizony S, Warrington KJ, Sloane J, Giannelou A, Nivens MC, Akinlade B, Wong W, Bhore R, Lin Y, Buttgereit F, Devauchelle-Pensec V, Rubbert-Roth A, Yancopoulos GD, Marrache F, Patel N, Dasgupta B; SAPHYR Investigators. Spiera RF, et al. N Engl J Med. 2023 Oct 5;389(14):1263-1272. doi: 10.1056/NEJMoa2303452. N Engl J Med. 2023. PMID: 37792612 Clinical Trial.
Reply.
Rivière E, Pascaud J, Mariette X, Nocturne G. Rivière E, et al. Among authors: nocturne g. Arthritis Rheumatol. 2022 Apr;74(4):732-733. doi: 10.1002/art.42004. Epub 2022 Feb 21. Arthritis Rheumatol. 2022. PMID: 34694060 No abstract available.
Reply.
Nocturne G, Seror R, Mariette X. Nocturne G, et al. Arthritis Rheumatol. 2016 May;68(5):1319-20. doi: 10.1002/art.39584. Arthritis Rheumatol. 2016. PMID: 26749273 No abstract available.
Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells.
Khatri B, Tessneer KL, Rasmussen A, Aghakhanian F, Reksten TR, Adler A, Alevizos I, Anaya JM, Aqrawi LA, Baecklund E, Brun JG, Bucher SM, Eloranta ML, Engelke F, Forsblad-d'Elia H, Glenn SB, Hammenfors D, Imgenberg-Kreuz J, Jensen JL, Johnsen SJA, Jonsson MV, Kvarnström M, Kelly JA, Li H, Mandl T, Martín J, Nocturne G, Norheim KB, Palm Ø, Skarstein K, Stolarczyk AM, Taylor KE, Teruel M, Theander E, Venuturupalli S, Wallace DJ, Grundahl KM, Hefner KS, Radfar L, Lewis DM, Stone DU, Kaufman CE, Brennan MT, Guthridge JM, James JA, Scofield RH, Gaffney PM, Criswell LA, Jonsson R, Eriksson P, Bowman SJ, Omdal R, Rönnblom L, Warner B, Rischmueller M, Witte T, Farris AD, Mariette X, Alarcon-Riquelme ME; PRECISESADS Clinical Consortium; Shiboski CH; Sjögren’s International Collaborative Clinical Alliance (SICCA); Wahren-Herlenius M, Ng WF; UK Primary Sjögren’s Syndrome Registry; Sivils KL, Adrianto I, Nordmark G, Lessard CJ. Khatri B, et al. Among authors: nocturne g. Nat Commun. 2022 Jul 27;13(1):4287. doi: 10.1038/s41467-022-30773-y. Nat Commun. 2022. PMID: 35896530 Free PMC article.
Salivary gland epithelial cells from patients with Sjögren's syndrome induce B-lymphocyte survival and activation.
Rivière E, Pascaud J, Tchitchek N, Boudaoud S, Paoletti A, Ly B, Dupré A, Chen H, Thai A, Allaire N, Jagla B, Mingueneau M, Nocturne G, Mariette X. Rivière E, et al. Among authors: nocturne g. Ann Rheum Dis. 2020 Nov;79(11):1468-1477. doi: 10.1136/annrheumdis-2019-216588. Epub 2020 Aug 25. Ann Rheum Dis. 2020. PMID: 32843324 Free article.
Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome.
Seror R, Baron G, Camus M, Cornec D, Perrodeau E, Bowman SJ, Bombardieri M, Bootsma H, Gottenberg JE, Fisher B, Hueber W, van Roon JA, Devauchelle-Pensec V, Gergely P, Mariette X, Porcher R; NECESSITY WP5 - STAR development working group; NECESSITY WP5- STAR development working group. Seror R, et al. Ann Rheum Dis. 2022 Jul;81(7):979-989. doi: 10.1136/annrheumdis-2021-222054. Epub 2022 Apr 7. Ann Rheum Dis. 2022. PMID: 35393271 Free PMC article.
Immune Checkpoint Inhibitor-induced Sicca Syndrome.
Bitoun S, Rousseau A, Gosset M, Belkhir R, Lazure T, Mariette X, Nocturne G. Bitoun S, et al. Among authors: nocturne g. Rheum Dis Clin North Am. 2024 May;50(2):291-300. doi: 10.1016/j.rdc.2024.02.004. Rheum Dis Clin North Am. 2024. PMID: 38670727 Review.
French national diagnostic and care protocol for Sjögren's disease.
Devauchelle-Pensec V, Mariette X, Benyoussef AA, Boisrame S, Cochener B, Cornec D, Nocturne G, Gottenberg JE, Hachulla E, Labalette P, Le Guern V, M'Bwang Seppoh R, Morel J, Orliaguet M, Saraux A, Seror R, Costedoat-Chalumeau N; Collaborators. Devauchelle-Pensec V, et al. Among authors: nocturne g. Rev Med Interne. 2023 Aug;44(8):423-457. doi: 10.1016/j.revmed.2023.07.001. Epub 2023 Jul 13. Rev Med Interne. 2023. PMID: 37453854 Review.
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts.
Nguyen Y, Nocturne G, Henry J, Ng WF, Belkhir R, Desmoulins F, Bergé E, Morel J, Perdriger A, Dernis E, Devauchelle-Pensec V, Sène D, Dieudé P, Couderc M, Fauchais AL, Larroche C, Vittecoq O, Salliot C, Hachulla E, Le Guern V, Gottenberg JE, Mariette X, Seror R. Nguyen Y, et al. Among authors: nocturne g. Lancet Rheumatol. 2024 Apr;6(4):e216-e225. doi: 10.1016/S2665-9913(23)00340-5. Epub 2024 Mar 1. Lancet Rheumatol. 2024. PMID: 38437852 Free PMC article.
123 results